Patents by Inventor Cynthia H. Scanlan

Cynthia H. Scanlan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A34 and A33-like 3 DNA protein, antibodies thereto and methods of treatment using same
    Patent number: 8440807
    Abstract: Polynucleotide molecules and polypeptide molecules A34 and A33-like 3 are described, as well as antibodies to polypeptide molecules A34 and A33-like 3. Also described are methods of detecting cancers expressing these polypeptides, and methods and kits for diagnosing said cancers, and methods of inhibiting effects of a cancer in a patient.
    Type: Grant
    Filed: September 15, 2011
    Date of Patent: May 14, 2013
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Gerd Ritter, Lloyd Old, Achim Jungbluth, Cynthia H. Scanlan
  • Human sarcoma-associated antigens
    Patent number: 8252903
    Abstract: The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.
    Type: Grant
    Filed: January 6, 2010
    Date of Patent: August 28, 2012
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Matthew J. Scanlan, Cynthia H. Scanlan, legal representative, Sang-Yull Lee, Lloyd J. Old
  • A34 AND A33-LIKE 3 DNA PROTEIN, ANTIBODIES THERETO AND METHODS OF TREATMENT USING SAME
    Publication number: 20120039892
    Abstract: Polynucleotide molecules and polypeptide molecules A34 and A33-like 3 are described, as well as antibodies to polypeptide molecules A34 and A33-like 3. Also described are methods of detecting cancers expressing these polypeptides, and methods and kits for diagnosing said cancers, and methods of inhibiting effects of a cancer in a patient.
    Type: Application
    Filed: September 15, 2011
    Publication date: February 16, 2012
    Applicant: Ludwig Institute for Cancer Research
    Inventors: Matthew Scanlan, Cynthia H. Scanlan, Gerd Ritter, Lloyd Old, Achim Jungbluth
  • Cancer-testis antigens
    Publication number: 20110177079
    Abstract: The invention relates to cancer-testis antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of novel cancer-testis (CT) antigens.
    Type: Application
    Filed: September 8, 2005
    Publication date: July 21, 2011
    Applicants: Ludwig Institute for Cancer Research, Cornell Research Foundation, Inc.
    Inventors: Yao-Tseng Chen, Lloyd J. Old, Andrew J.G. Simpson, Victor C. Jongeneel, Matthew J. Scanlan, Cynthia H. Scanlan
  • Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof
    Patent number: 7795409
    Abstract: The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.
    Type: Grant
    Filed: January 30, 2008
    Date of Patent: September 14, 2010
    Assignees: Ludwig Institute for Cancer Research, Cornell Research Foundation, Inc.
    Inventors: Dirk Jager, Elisabeth Stockert, Barry C. Picker, legal representative, Matthew Scanlan, Cynthia H. Scanlan, legal representative, Ali Gure, Elke Jager, Alexander Knuth, Lloyd Old, Yao-Tseng Chen
  • HUMAN SARCOMA-ASSOCIATED ANTIGENS
    Publication number: 20100172910
    Abstract: The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.
    Type: Application
    Filed: January 6, 2010
    Publication date: July 8, 2010
    Applicant: Ludwig Institute for Cancer Research Ltd.
    Inventors: Matthew J. Scanlan, Cynthia H. Scanlan, Sang-Yull Lee, Lloyd J. Old
  • Human sarcoma-associated antigens
    Patent number: 7662917
    Abstract: The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.
    Type: Grant
    Filed: September 30, 2003
    Date of Patent: February 16, 2010
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Matthew J. Scanlan, Cynthia H. Scanlan, legal representative, Sang-Yull Lee, Lloyd J. Old
  • Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof
    Publication number: 20090203123
    Abstract: The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.
    Type: Application
    Filed: January 30, 2008
    Publication date: August 13, 2009
    Inventors: Dirk Jager, Elisabeth Stockert, Matthew Scanlan, Ali Gure, Elke Jager, Alexander Knuth, Lloyd Old, Yao-Tseng Chen, Barry C. Picker, Cynthia H. Scanlan
  • Human Sarcoma-Associated Antigens
    Publication number: 20080089888
    Abstract: The invention relates to sarcoma-associated antigens and the nucleic acid molecules that encode them. The invention further relates to the use of the nucleic acid molecules, polypeptides and fragments thereof associated with sarcoma in methods and compositions for the diagnosis and treatment of diseases, such as cancer. More specifically, the invention relates to the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.
    Type: Application
    Filed: September 30, 2003
    Publication date: April 17, 2008
    Applicant: Ludwig Institute for Cancer Research
    Inventors: Matthew J. Scanlan, Cynthia H. Scanlan, Sang-Yull Lee, Lloyd J. Old
  • Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
    Patent number: 7354992
    Abstract: The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.
    Type: Grant
    Filed: December 4, 2003
    Date of Patent: April 8, 2008
    Assignees: Ludwig Institute For Cancer Research, Cornell Research Foundation, Inc.
    Inventors: Dirk Jager, Barry C. Picker, legal representative, Cynthia H. Scanlan, legal representative, Ali Gure, Elke Jager, Alexander Knuth, Lloyd Old, Yao-Tseng Chen, Elisabeth Stockert, Matthew Scanlan
  • Cancer-testis antigens
    Publication number: 20040235066
    Abstract: Cancer-testis (CT) antigens have been identified by screening public databases for transcripts that are expressed in tumor tissues and a limited set of normal tissues, or by screening for genes that are expressed in cancer and testis tissues (but not other normal tissues). The invention relates to nucleic acids and encoded polypeptides which are CT antigens expressed in patients afflicted with cancer. The invention provides, inter alia isolated nucleic acid molecules, expression vectors containing those molecules and host cells transfected with those molecules. The invention also provides isolated proteins and peptides, antibodies to those proteins and peptides and cytotoxic T lymphocytes which recognize the proteins and peptides. Fragments of the foregoing including functional fragments and variants also are provided. Kits containing the foregoing molecules additionally are provided.
    Type: Application
    Filed: June 21, 2004
    Publication date: November 25, 2004
    Inventors: Lloyd J. Old, Cynthia H. Scanlan, Yao-Tseng Chen